DXB vs VHL

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

37LOW

VHL

VITASORA FPO [VHL]

37LOW

Score Breakdown

DXB VHL
Technical
51
47
Catalyst
58
51
Sentiment
50
50
Fundamental
82
48
Momentum
39
45
Risk Gate
50
45

Key Metrics

DXB Metric VHL
$198.1MMarket Cap$40.7M
1.2MAvg Volume (20d)615K
+0.1%Short InterestN/A
$0.78552-Week High$0.047
$0.31052-Week Low$0.018
+1.6%Daily Change+0.0%
$0.325Entry Price$0.020
-594.5%ROE-106.3%
-219.9%Profit Margin-231.4%

Active Signals

DXB Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (4% of range)

VHL Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Drifting lower — down 4.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.1 quarters)
Moderate P/S ratio (8.1x)
Strong revenue growth (+84%)

Ask Scout AI to compare DXB and VHL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → VHL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).